Fig. 2: TXNDC9 overexpression was correlated with poor prognosis in HCC patients. | Cell Death & Disease

Fig. 2: TXNDC9 overexpression was correlated with poor prognosis in HCC patients.

From: TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network

Fig. 2

a Kaplan–Meier plots of overall survival based on the TXNDC9 expression in HCC tissues of our cohort with the log-rank test. b Kaplan–Meier plots of overall survival based on TXNDC9 expression in HCC tissues of the TCGA cohort. The top 40% of TXNDC9 expression were identified as TXNDC9 high-expression group, while the bottom 40% of TXNDC9 expression were identified as TXNDC9 low-expression group, and log-rank analysis was used to test for significance

Back to article page